Skip to main navigation Skip to search Skip to main content

Fluid therapy in cardiac surgery patients

Jan Schumacher*, K. F. Klotz

*Corresponding author for this work

Abstract

Fluid therapy in cardiac surgery patients should be managed according to predefined target parameters. In case infusions of crystalloid solutions are applied, full-electrolytes preparations should be preferred. Both, HES and gelatin products - under certain conditions human albumin as well - may be used as colloid solutions. At present, existing literature does not allow to make a final judgement as to the question whether crystalloid or colloid fluid substitution fluids should be favoured for cardiac surgery. Nevertheless, most German cardiac surgery clinicians use artificial colloid solutions, mainly applying middle-molecular hydroxyethylene starch derivatives, followed by crystalloid solutions.

Original languageEnglish
JournalApplied Cardiopulmonary Pathophysiology
Volume13
Issue number2
Pages (from-to)138-142
Number of pages5
ISSN0920-5268
Publication statusPublished - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Fluid therapy in cardiac surgery patients'. Together they form a unique fingerprint.

Cite this